CTIS2022-500618-24-00招募中1 期
Prostate medication, metabolism and gut microbiota, PROMED.
Turku University Central Hospital0 个研究点目标入组 100 人开始时间: 2022年6月2日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 65+（—）
- 性别
- Male
入选标准
- •histologically confirmed prostate cancer or benign prostate hyperplasia, provision of signed and dated informed consent form, ability and stated willingness to comply with all study procedures and availablity for the duration of the study, male aged >18 years
排除标准
- •inability to comply with study procedures or unwillingness to participate in the study, age < 18 years
研究者
相似试验
招募中
4 期
Prostate Medication, Metabolism and Gut MicrobiotaProstatic HyperplasiaProstate CancerNCT06001619Turku University Hospital100
招募中
不适用
study of PROstate cancer, gut MicrobIome, and lifeStylE in JAPAN (PROMISE-JAPAN)Prostate cancerJPRN-UMIN000043489Kindai University Faculty of Medicine600
招募中
不适用
Prostate Metabolism, Cancer Risk and Gut MicrobiotaProstate HyperplasiaProstate CancerNCT06116851Turku University Hospital300
已完成
不适用
Intestinal Microbiota in Prostate Cancer Patients as a Biomarker for Radiation-INduced Toxicity (IMPRINT)Prostate AdenocarcinomaProstate CancerProstatic NeoplasmsNCT04638049University Hospital, Ghent50
Unknown
不适用
Evaluation of Gut Microbiome in Patients With Prostate CancerProstate CancerNCT03709485Ziv Hospital150